Non-invasive Glucose Monitoring Devices Market to Grow by USD 22.49 Mn, Abbott Laboratories and BlueSemi Among Key Vendors - Technavio

News provided by

Feb 13, 2023, 18:30 ET

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- The Non-invasive Glucose Monitoring Devices Market by Product, End-user, and Geography - Forecast and Analysis 2023-2027 report has been published by Technavio. Market size is forecast to grow by USD 22.49 million between 2022 and 2027 at a CAGR of 15.68%. The report includes historic market data from 2017 to 2021. In 2017, the market was valued at USD 13.48 million. The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. Download A PDF Sample Report

Technavio has announced its latest market research report titled Global Non-invasive Glucose Monitoring Devices Market 2023-2027

Regional Analysis

By region, the global non-invasive glucose monitoring devices market is segmented into North America, Europe, Asia, and Rest of World (ROW). North America will account for 49% of market growth during the forecast period. Factors such as the increasing prevalence of diabetes, the rising number of product launches, and the growing presence of regional and global vendors are driving the growth of the non-invasive glucose monitoring devices market in North America. Buy the report

Company Profiles

The non-invasive glucose monitoring devices market report includes information on the key products and recent developments of leading vendors, including:

Abbott Laboratories - The company offers non invasive glucose monitoring devices such as FreeStyle Libre.
BoydSense SAS - The company offers non invasive glucose monitoring devices such as non invasive diabetes monitoring technology that uses breath based biomarkers to predict glucose levels.
Cnoga - The company offers non invasive glucose monitoring devices such as CoG Hybrid Glucometer.
Dexcom Inc. - The company offers non invasive glucose monitoring devices such as Dexcom G6.

Market Dynamics

The market is driven by factors such as the increasing prevalence of diabetes and the growing number of government programs, product launches, and increasing demand for non-invasive procedures. However, the high costs associated with non-invasive glucose monitoring devices are hindering market growth.

Competitive Analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share among others. Request a Sample

Market Segmentation

By product, the market is segmented into wearable and non-wearable. The wearable accounted for the largest share of the market in 2022.
By geography, the market is segmented into North America, Europe, Asia, and Rest of World (ROW). North America held the largest share of the market in 2022.

Related Reports:

The anesthesia monitoring devices market is estimated to grow at a CAGR of 10.67% between 2022 and 2027. The size of the market is forecast to increase by USD 1,108.53 million. The increasing number of surgeries requiring general anesthesia is notably driving the market growth, although factors such as the lack of trained anesthesiologists may impede the market growth.
The cardiopulmonary stress testing systems market is estimated to grow at a CAGR of 6.92% between 2022 and 2027. The size of the market is forecast to increase by USD 2,103.24 million. The increasing number of heart specialty centers is notably driving the market growth, although factors such as the high cost of stress testing devices may impede the market growth.

Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to Technavio Insights

What are the key data covered in this non-invasive glucose monitoring devices market report?

CAGR of the market during the forecast period.
Detailed information on factors that will drive the growth of the market between 2023 and 2027
Precise estimation of the size of the non-invasive glucose monitoring devices market and its contribution to the parent market.
Accurate predictions about upcoming trends and changes in consumer behavior.
Growth of the market across North America, Europe, Asia, and Rest of World (ROW).
A thorough analysis of the market's competitive landscape and detailed information about vendors.
Comprehensive analysis of factors that will challenge the growth of non-invasive glucose monitoring devices market vendors.

Non-invasive Glucose Monitoring Devices Market Scope
Report Coverage	Details
Page number	157
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 15.68%
Market growth 2023-2027	USD 22.49 million
Market structure	Fragmented
YoY growth 2022-2023 (%)	14.06
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 49%
Key countries	US, Germany, UK, India, and China
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	Abbott Laboratories, Ascensia Diabetes Care Holdings AG, BlueSemi, BoydSense SAS, Cnoga, Dexcom Inc., DiaMonTech AG, Eser Co., F. Hoffmann La Roche Ltd., Gluco Rx Ltd., GlucoTrack Inc., Informed Data Systems Inc. and One Drop., Medtronic Plc, Meta Materials Inc., Nemaura Medical Inc., Platinum Equity Advisors LLC, Rite Aid Corp., Taiwan Biophotonic Co., Tandem Diabetes Care Inc., and Walgreens Boots Alliance Inc.
Market dynamics	Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of contents:

1 Executive Summary

1.1 Market overview

Exhibit 01: Executive Summary – Chart on Market Overview
Exhibit 02: Executive Summary – Data Table on Market Overview
Exhibit 03: Executive Summary – Chart on Global Market Characteristics
Exhibit 04: Executive Summary – Chart on Market by Geography
Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
Exhibit 06: Executive Summary – Chart on Market Segmentation by Route of Administration
Exhibit 07: Executive Summary – Chart on Incremental Growth
Exhibit 08: Executive Summary – Data Table on Incremental Growth
Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem

Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition

Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis

Exhibit 13: Market segments

3.3 Market size 2022

3.4 Market outlook: Forecast for 2022-2027

Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global anesthesia drugs market 2017 - 2021

Exhibit 18: Historic Market Size – Data Table on Global anesthesia drugs market 2017 - 2021 ($ million)

4.2 Type Segment Analysis 2017 - 2021

Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ million)

4.3 Route of Administration Segment Analysis 2017 - 2021

Exhibit 20: Historic Market Size – Route of Administration Segment 2017 - 2021 ($ million)

4.4 Geography Segment Analysis 2017 - 2021

Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

4.5 Country Segment Analysis 2017 - 2021

Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary

Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

5.2 Bargaining power of buyers

Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

5.3 Bargaining power of suppliers

Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

5.4 Threat of new entrants

Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

5.5 Threat of substitutes

Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

5.6 Threat of rivalry

Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

5.7 Market condition

Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

6.1 Market segments

Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)

6.2 Comparison by Type

Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type

6.3 General anesthesia - Market size and forecast 2022-2027

Exhibit 34: Chart on General anesthesia - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on General anesthesia - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on General anesthesia - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on General anesthesia - Year-over-year growth 2022-2027 (%)

6.4 Local and regional anesthesia - Market size and forecast 2022-2027

Exhibit 38: Chart on Local and regional anesthesia - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Local and regional anesthesia - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Local and regional anesthesia - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Local and regional anesthesia - Year-over-year growth 2022-2027 (%)

6.5 Market opportunity by Type

Exhibit 42: Market opportunity by Type ($ million)

7 Market Segmentation by Route of Administration

7.1 Market segments

Exhibit 43: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibit 44: Data Table on Route of Administration - Market share 2022-2027 (%)

7.2 Comparison by Route of Administration

Exhibit 45: Chart on Comparison by Route of Administration
Exhibit 46: Data Table on Comparison by Route of Administration

7.3 Intravenous - Market size and forecast 2022-2027

Exhibit 47: Chart on Intravenous - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Intravenous - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Intravenous - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Intravenous - Year-over-year growth 2022-2027 (%)

7.4 Inhalational - Market size and forecast 2022-2027

Exhibit 51: Chart on Inhalational - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Inhalational - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Inhalational - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Inhalational - Year-over-year growth 2022-2027 (%)

7.5 Others - Market size and forecast 2022-2027

Exhibit 55: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Others - Year-over-year growth 2022-2027 (%)

7.6 Market opportunity by Route of Administration

Exhibit 59: Market opportunity by Route of Administration ($ million)

8 Customer Landscape

8.1 Customer landscape overview

Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation

Exhibit 61: Chart on Market share by geography 2022-2027 (%)
Exhibit 62: Data Table on Market share by geography 2022-2027 (%)

9.2 Geographic comparison

Exhibit 63: Chart on Geographic comparison
Exhibit 64: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2022-2027

Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)

9.4 Europe - Market size and forecast 2022-2027

Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)

9.5 Asia - Market size and forecast 2022-2027

Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)

9.6 Rest of World (ROW) - Market size and forecast 2022-2027

Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

9.7 US - Market size and forecast 2022-2027

Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)

9.8 Germany - Market size and forecast 2022-2027

Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)

9.9 UK - Market size and forecast 2022-2027

Exhibit 89: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on UK - Year-over-year growth 2022-2027 (%)

9.10 China - Market size and forecast 2022-2027

Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)

9.11 India - Market size and forecast 2022-2027

Exhibit 97: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on India - Year-over-year growth 2022-2027 (%)

9.12 Market opportunity by geography

Exhibit 101: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges

Exhibit 102: Impact of drivers and challenges in 2022 and 2027

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape

Exhibit 103: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption

Exhibit 104: Overview on factors of disruption

11.4 Industry risks

Exhibit 105: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered

Exhibit 106: Vendors covered

12.2 Market positioning of vendors

Exhibit 107: Matrix on vendor position and classification

12.3 AbbVie Inc.

Exhibit 108: AbbVie Inc. - Overview
Exhibit 109: AbbVie Inc. - Product / Service
Exhibit 110: AbbVie Inc. - Key news
Exhibit 111: AbbVie Inc. - Key offerings

12.4 AstraZeneca Plc

Exhibit 112: AstraZeneca Plc - Overview
Exhibit 113: AstraZeneca Plc - Product / Service
Exhibit 114: AstraZeneca Plc - Key news
Exhibit 115: AstraZeneca Plc - Key offerings

12.5 Avet Pharmaceuticals Inc.

Exhibit 116: Avet Pharmaceuticals Inc. - Overview
Exhibit 117: Avet Pharmaceuticals Inc. - Product / Service
Exhibit 118: Avet Pharmaceuticals Inc. - Key offerings

12.6 B Braun Melsungen AG

Exhibit 119: B Braun Melsungen AG - Overview
Exhibit 120: B Braun Melsungen AG - Business segments
Exhibit 121: B Braun Melsungen AG - Key news
Exhibit 122: B Braun Melsungen AG - Key offerings
Exhibit 123: B Braun Melsungen AG - Segment focus

12.7 Baxter International Inc.

Exhibit 124: Baxter International Inc. - Overview
Exhibit 125: Baxter International Inc. - Business segments
Exhibit 126: Baxter International Inc. - Key news
Exhibit 127: Baxter International Inc. - Key offerings
Exhibit 128: Baxter International Inc. - Segment focus

12.8 Eisai Co. Ltd.

Exhibit 129: Eisai Co. Ltd. - Overview
Exhibit 130: Eisai Co. Ltd. - Business segments
Exhibit 131: Eisai Co. Ltd. - Key offerings
Exhibit 132: Eisai Co. Ltd. - Segment focus

12.9 Fresenius SE and Co. KGaA

Exhibit 133: Fresenius SE and Co. KGaA - Overview
Exhibit 134: Fresenius SE and Co. KGaA - Business segments
Exhibit 135: Fresenius SE and Co. KGaA - Key news
Exhibit 136: Fresenius SE and Co. KGaA - Key offerings
Exhibit 137: Fresenius SE and Co. KGaA - Segment focus

12.10 Glenmark Pharmaceuticals Ltd.

Exhibit 138: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 139: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 140: Glenmark Pharmaceuticals Ltd. - Key offerings

12.11 Hikma Pharmaceuticals Plc

Exhibit 141: Hikma Pharmaceuticals Plc - Overview
Exhibit 142: Hikma Pharmaceuticals Plc - Business segments
Exhibit 143: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 144: Hikma Pharmaceuticals Plc - Segment focus

12.12 Maruishi Pharmaceutical Co. Ltd.

Exhibit 145: Maruishi Pharmaceutical Co. Ltd. - Overview
Exhibit 146: Maruishi Pharmaceutical Co. Ltd. - Product / Service
Exhibit 147: Maruishi Pharmaceutical Co. Ltd. - Key offerings

12.13 Merck and Co. Inc.

Exhibit 148: Merck and Co. Inc. - Overview
Exhibit 149: Merck and Co. Inc. - Business segments
Exhibit 150: Merck and Co. Inc. - Key news
Exhibit 151: Merck and Co. Inc. - Key offerings
Exhibit 152: Merck and Co. Inc. - Segment focus

12.14 Novartis AG

Exhibit 153: Novartis AG - Overview
Exhibit 154: Novartis AG - Business segments
Exhibit 155: Novartis AG - Key offerings
Exhibit 156: Novartis AG - Segment focus

12.15 Pfizer Inc.

Exhibit 157: Pfizer Inc. - Overview
Exhibit 158: Pfizer Inc. - Product / Service
Exhibit 159: Pfizer Inc. - Key news
Exhibit 160: Pfizer Inc. - Key offerings

12.16 Piramal Enterprises Ltd.

Exhibit 161: Piramal Enterprises Ltd. - Overview
Exhibit 162: Piramal Enterprises Ltd. - Business segments
Exhibit 163: Piramal Enterprises Ltd. - Key offerings
Exhibit 164: Piramal Enterprises Ltd. - Segment focus

12.17 Septodont Holding

Exhibit 165: Septodont Holding - Overview
Exhibit 166: Septodont Holding - Product / Service
Exhibit 167: Septodont Holding - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist

Exhibit 168: Inclusions checklist
Exhibit 169: Exclusions checklist

13.3 Currency conversion rates for US$

Exhibit 170: Currency conversion rates for US$

13.4 Research methodology

Exhibit 171: Research methodology
Exhibit 172: Validation techniques employed for market sizing
Exhibit 173: Information sources

13.5 List of abbreviations

Exhibit 174: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio